NewSquare Capital’s Antares Pharma, Inc. ATRS Stock Holding History

NewSquare Capital’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-21,611	Closed	-$65K	–	377
2019 Q1	$65K	Hold	21,611	–	–	0.01%	151
2018 Q4	$59K	Buy	21,611 +5,460	+34%	+$18K	0.01%	146
2018 Q3	$54K	Buy	16,151 +8,893	+123%	+$27.5K	0.01%	166
2018 Q2	$20K	Hold	7,258	–	–	﹤0.01%	213
2018 Q1	$16K	Hold	7,258	–	–	﹤0.01%	214
2017 Q4	$14K	Hold	7,258	–	–	﹤0.01%	216
2017 Q3	$24K	Buy	7,258 +3,508	+94%	+$10.8K	0.01%	169
2017 Q2	$12K	Hold	3,750	–	–	﹤0.01%	187
2017 Q1	$11K	Hold	3,750	–	–	﹤0.01%	191
2016 Q4	$9K	Hold	3,750	–	–	﹤0.01%	219
2016 Q3	$6K	Hold	3,750	–	–	﹤0.01%	296
2016 Q2	$4K	Hold	3,750	–	–	﹤0.01%	303
2016 Q1	$3K	Buy	+3,750	New	+$3.63K	﹤0.01%	376

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

NewSquare Capital's ATRS Position: Q2 2019 in Review

NewSquare Capital sold out of Antares Pharma, Inc. (ATRS) in Q2 2019, closing a stake of 21,611 shares — an estimated $65K sold.

NewSquare Capital first reported a position in ATRS in Q1 2016 and held it in 13 quarters. The position peaked at $65K in Q1 2019. 127 funds tracked by Wall St. Rank hold ATRS as of Q2 2019.

NewSquare Capital reported no remaining Antares Pharma, Inc. position as of Q2 2019 after selling out during the quarter.
NewSquare Capital sold 21,611 Antares Pharma, Inc. shares in Q2 2019, an estimated $65K.
NewSquare Capital first reported a position in Antares Pharma, Inc. in Q1 2016 and held it in 13 quarters.
NewSquare Capital's Antares Pharma, Inc. position peaked at $65K in Q1 2019.
127 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2019.

Based on NewSquare Capital's 13F filing for Q2 2019, filed 20 Aug 2019.